autoimmune disorders

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Tacrolimus Market Poised for 74% Growth Through 2035 as Transplants Surge

Global tacrolimus market to reach $12.7B by 2035 from $7.3B in 2025, driven by rising organ transplants and autoimmune disease prevalence.
PFENVSABTRHHBYVTRS+3healthcare infrastructureorgan transplant
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

TScan Therapeutics Advances TCR Cell Therapy Pipeline With FDA Clearance, Conference Participation

TScan Therapeutics secures FDA clearance for two IND applications and completes Phase 1 trial enrollment using commercial-scale manufacturing, advancing its TCR cell therapy pipeline.
TCRXclinical-stage biotechsolid tumors